Recombinant interferon-ALPHA2b and high
β
R. K. Ganjoo; P. W. M. Johnson; M. L. Evans; A Williams; A. Z. S. Rohatiner; T.
π
Article
π
1993
π
John Wiley and Sons
π
English
β 483 KB
## Abstract Twentyβone patients with referactory myeloma (10 primary resistant and 11 relapsed resistant) were treated with a combination of high dose methyl prednisolone and recombinant interferon alpha2b (IFNβΞ±2b). This treatment included three megaunits/m^2^ of IFNβΞ±2b three times a week for 12